Finding new treatments for blood cancers like AML and MDS
MD NET
This study is looking for better ways to treat people with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) by finding new treatments that work best for each person based on their unique biology.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11101092 on NIH RePORTER |
What this research studies
This research focuses on improving treatment options for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) by developing new therapeutic strategies. It involves a master screening protocol to evaluate patients for clinical trials and a data support structure for analyzing biomarkers related to treatment response and resistance. The study aims to identify molecular targets and biomarkers that can help tailor therapies to individual patients, ultimately enhancing treatment effectiveness and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Not a fit: Patients with other types of blood cancers or those not diagnosed with AML or MDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with AML and MDS.
How similar studies have performed: Other research initiatives have shown promise in developing targeted therapies for blood cancers, indicating that this approach has potential for success.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Parchment, Ralph — Leidos Biomedical Research, INC.
- Study coordinator: Parchment, Ralph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.